BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21089350)

  • 21. Molecular characterization of the ERGIC-53 gene in two Japanese patients with combined factor V-factor VIII deficiency.
    Dansako H; Ishimaru F; Takai Y; Tomoda J; Nakase K; Fujii K; Ogama Y; Kozuka T; Sezaki N; Honda K; Harada M
    Ann Hematol; 2001 May; 80(5):292-4. PubMed ID: 11446732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heat shock induces preferential translation of ERGIC-53 and affects its recycling pathway.
    Spatuzza C; Renna M; Faraonio R; Cardinali G; Martire G; Bonatti S; Remondelli P
    J Biol Chem; 2004 Oct; 279(41):42535-44. PubMed ID: 15292203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VIPL, a VIP36-like membrane protein with a putative function in the export of glycoproteins from the endoplasmic reticulum.
    Neve EP; Svensson K; Fuxe J; Pettersson RF
    Exp Cell Res; 2003 Aug; 288(1):70-83. PubMed ID: 12878160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of ERGIC-53: its structure, functions, regulation and relations with diseases.
    Zhang YC; Zhou Y; Yang CZ; Xiong DS
    Histol Histopathol; 2009 Sep; 24(9):1193-204. PubMed ID: 19609866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel missense mutation causing abnormal LMAN1 in a Japanese patient with combined deficiency of factor V and factor VIII.
    Yamada T; Fujimori Y; Suzuki A; Miyawaki Y; Takagi A; Murate T; Sano M; Matsushita T; Saito H; Kojima T
    Am J Hematol; 2009 Nov; 84(11):738-42. PubMed ID: 19787799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion of 3 residues from the C-terminus of MCFD2 affects binding to ERGIC-53 and causes combined factor V and factor VIII deficiency.
    Nyfeler B; Kamiya Y; Boehlen F; Yamamoto K; Kato K; de Moerloose P; Hauri HP; Neerman-Arbez M
    Blood; 2008 Feb; 111(3):1299-301. PubMed ID: 17971482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The sugar-binding ability of ERGIC-53 is enhanced by its interaction with MCFD2.
    Kawasaki N; Ichikawa Y; Matsuo I; Totani K; Matsumoto N; Ito Y; Yamamoto K
    Blood; 2008 Feb; 111(4):1972-9. PubMed ID: 18056485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The COPII pathway and hematologic disease.
    Khoriaty R; Vasievich MP; Ginsburg D
    Blood; 2012 Jul; 120(1):31-8. PubMed ID: 22586181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII.
    Nichols WC; Seligsohn U; Zivelin A; Terry VH; Hertel CE; Wheatley MA; Moussalli MJ; Hauri HP; Ciavarella N; Kaufman RJ; Ginsburg D
    Cell; 1998 Apr; 93(1):61-70. PubMed ID: 9546392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A synonymous mutation in LMAN1 creates an ectopic splice donor site and causes combined deficiency of FV and FVIII.
    Zhu M; DAS V; Zheng C; Majumdar S; Zhang B
    J Thromb Haemost; 2012 Nov; 10(11):2407-9. PubMed ID: 23006835
    [No Abstract]   [Full Text] [Related]  

  • 31. ERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency families.
    Nichols WC; Terry VH; Wheatley MA; Yang A; Zivelin A; Ciavarella N; Stefanile C; Matsushita T; Saito H; de Bosch NB; Ruiz-Saez A; Torres A; Thompson AR; Feinstein DI; White GC; Negrier C; Vinciguerra C; Aktan M; Kaufman RJ; Ginsburg D; Seligsohn U
    Blood; 1999 Apr; 93(7):2261-6. PubMed ID: 10090935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of Mac-2BP secretion is mediated by its N-glycan binding to ERGIC-53.
    Chen Y; Hojo S; Matsumoto N; Yamamoto K
    Glycobiology; 2013 Jul; 23(7):904-16. PubMed ID: 23550150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in the MCFD2 gene are predominant among patients with hereditary combined FV and FVIII deficiency (F5F8D) in India.
    Jayandharan G; Spreafico M; Viswabandya A; Chandy M; Srivastava A; Peyvandi F
    Haemophilia; 2007 Jul; 13(4):413-9. PubMed ID: 17610559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combined deficiency of clotting factor V and factor VIII: about three siblings].
    Mamad H; Benkirane S; Aissaoui YE; Berchane Z; Masrar A
    Pan Afr Med J; 2021; 39():65. PubMed ID: 34422188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent developments in the understanding of the combined deficiency of FV and FVIII.
    Zhang B
    Br J Haematol; 2009 Apr; 145(1):15-23. PubMed ID: 19183188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel mutation in the MCFD2 gene in a Tunisian family with combined factor V and VIII deficiency.
    Hejer E; Adnen LM; Asma J; Ibtihel M; Benammar-Elgaaied A; Gouider E
    Tunis Med; 2012 Apr; 90(4):343-4. PubMed ID: 22535353
    [No Abstract]   [Full Text] [Related]  

  • 37. A new case of combined factor V and factor VIII deficiency further suggests that the LMAN1 M1T mutation is a frequent cause in Italian patients.
    D'Ambrosio R; Santacroce R; Di Perna P; Sarno M; Romondia A; Margaglione M
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):203-4. PubMed ID: 17287640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined FV and FVIII deficiency.
    Spreafico M; Peyvandi F
    Haemophilia; 2008 Nov; 14(6):1201-8. PubMed ID: 19141160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oligomerization and interacellular localization of the glycoprotein receptor ERGIC-53 is independent of disulfide bonds.
    Neve EP; Lahtinen U; Pettersson RF
    J Mol Biol; 2005 Dec; 354(3):556-68. PubMed ID: 16257008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotype-phenotype correlation in combined deficiency of factor V and factor VIII.
    Zhang B; Spreafico M; Zheng C; Yang A; Platzer P; Callaghan MU; Avci Z; Ozbek N; Mahlangu J; Haw T; Kaufman RJ; Marchant K; Tuddenham EG; Seligsohn U; Peyvandi F; Ginsburg D
    Blood; 2008 Jun; 111(12):5592-600. PubMed ID: 18391077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.